Trials / Sponsors / Memo Therapeutics AG
Memo Therapeutics AG
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients BK Viremia; BKV DNAemia | Phase 2 / Phase 3 | 2023-04-10 |
| Completed | Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers. BK Virus Nephropathy | Phase 1 | 2022-05-09 |
| Completed | To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID SARS-CoV-2 Infection | Phase 1 | 2022-04-26 |